Analysts love this biotech stock and give it major upside
The biotechnology sector has finally picked up steam after a tough 2022 — and for fund manager Hugh Dive, one stock stands out.
Source: cnbc.com
Stay updated with breaking news from Virfor Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The biotechnology sector has finally picked up steam after a tough 2022 — and for fund manager Hugh Dive, one stock stands out.